Lozen Pharma Ltd

Supplier
Summarized by Halo AI

Lozen Pharma is a developer and manufacturer of medicated lozenges and throat pops, utilizing confectionery as a novel drug delivery system (NDDS) to provide therapeutic treatments in convenient and palatable formats for global markets.

Company size
Less than 500 employees
Portfolio summary
Medicated, functional, and herbal lozenges (including hard candy, center-fill, and soft or powder center-fill varieties) and throat pops or lollipops utilizing confectionery as a novel drug delivery system (NDDS) for OTC healthcare and dietary supplements
Markets served
NA · EMEA · APAC · LATAM
Manufacturing locations
Two manufacturing facilities in Karnataka, India: Facility 1 in Savanur, Haveri (specializing in herbal lozenges, complementary medicine, food supplement lozenges, and throat pops) and Facility 2 in Dharwad (specializing in medicated lozenges)
R&D locations
Savanur, Karnataka, India · Dharwad, Karnataka, India

Lozen Pharma is a specialized manufacturer focused on the development and production of lozenges and throat pops as a novel drug delivery system (NDDS). The company utilizes confectionery formats to provide accurate dosages of natural or chemical active ingredients in palatable, convenient forms for various age groups. Their manufacturing processes allow for the customization of products, including sugar-free options and specific flavor or color profiles, designed to address diverse therapeutic healthcare needs. By operating as a dedicated partner in NDDS, they provide an alternative delivery method that is widely accepted by global regulators and consumers. The company's work enables pharmaceutical and healthcare organizations to transition therapeutic claims into user-friendly, consumer-centric delivery formats. With established international manufacturing facilities and an extensive reach across more than 40 countries, Lozen Pharma collaborates with clients to innovate and scale medicated and functional confectionery products to solve specific healthcare challenges. Their infrastructure is built to ensure quality, safety, and regulatory compliance in the production of these specialized dosage forms.

AI summary generated on Jun 11, 2026
OpenAlexOpenAlex

For general inquiries

SM
Sanjivani Mahajan
AGM - Business Development
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Co-developmentSupply/purchaseLicensing

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.